Other languages Rafael Holdings, Inc.

Equities

RFL

US75062E1064

Delayed Nyse Other stock markets 18:12:53 01/05/2024 BST			5-day change	1st Jan Change
1.61 ^USD	+1.26%		-5.85%	-12.02%

03-13	Rafael Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
2023	North American Morning Briefing : S&P 500 Eyes Record High as Rate Cut Hopes Underpin Sentiment	DJ

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Rafael Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	03-13
Rafael Holdings, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	12-14
Rafael Holdings, Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	30/10/23
Rafael Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended July 31, 2023	30/10/23
Rafael Holdings, Inc. Announces Resignation of Rachel Jonas as Director	26/10/23
Rafael Holdings, Inc. Announces Resignation of Boris Pasche as Director	09/08/23
Rafael Holdings, Inc.'s Equity Buyback Plan Extended till July 1, 2024.	30/06/23
Rafael Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	13/06/23
Cyclo Therapeutics Signs $5 Million Funding Deal with Rafael Holdings	05/06/23
Rafael Holdings, Inc. announces an Equity Buyback for $5 million worth of its shares.	04/04/23
Rafael Holdings, Inc. authorizes a Buyback Plan.	03/04/23
Rafael Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	14/03/23
Rafael Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	14/03/23
Rafael Holdings, Inc. Announces Resignation of David Polinsky as Chief of Staff	05/01/23
Rafael Holdings, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022	13/12/22
Rafael Holdings Explores Strategic Opportunities	14/11/22
Rafael Holdings, Inc. Reports Earnings Results for the Full Year Ended July 31, 2022	31/10/22
Rafael Holdings Closes on Sale of Headquarters Building; Shares Rise Pre-Bell	23/08/22
Rafael Holdings' Cornerstone Pharmaceuticals Completes Phase 1b Trial of Prospective Biliary Tract Cancer Therapy	03/08/22
Rafael Holdings Shares Halted Pending News Release on Pancreatic Cancer Data	01/07/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Rafael Holdings, Inc.

Equities

RFL

US75062E1064

Other languages

Filters